Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-22

FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Caplin Steriles Limited)

View source ↗

Summary

FDA approved the original application for PROCHLORPERAZINE EDISYLATE (Caplin Steriles Limited), a prochlorperazine edisylate antiemetic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prochlorperazine edisylate (Prochlorperazine edisylate)

Snippet

ORIG AP for PROCHLORPERAZINE EDISYLATE (PROCHLORPERAZINE EDISYLATE)